JP2025501214A5 - - Google Patents
Info
- Publication number
- JP2025501214A5 JP2025501214A5 JP2024539426A JP2024539426A JP2025501214A5 JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5 JP 2024539426 A JP2024539426 A JP 2024539426A JP 2024539426 A JP2024539426 A JP 2024539426A JP 2025501214 A5 JP2025501214 A5 JP 2025501214A5
- Authority
- JP
- Japan
- Prior art keywords
- ipsc
- antigen
- domain
- seq
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163294618P | 2021-12-29 | 2021-12-29 | |
| US63/294,618 | 2021-12-29 | ||
| US202263350156P | 2022-06-08 | 2022-06-08 | |
| US63/350,156 | 2022-06-08 | ||
| PCT/US2022/082441 WO2023129937A1 (en) | 2021-12-29 | 2022-12-27 | Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501214A JP2025501214A (ja) | 2025-01-17 |
| JP2025501214A5 true JP2025501214A5 (cg-RX-API-DMAC10.html) | 2026-01-13 |
Family
ID=85222536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539426A Pending JP2025501214A (ja) | 2021-12-29 | 2022-12-27 | 抗cd19/抗cd22キメラ抗原受容体を有する遺伝子操作細胞、およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250064934A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4456912A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025501214A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022423987A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3243966A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202342734A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023129937A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250090582A1 (en) * | 2022-06-08 | 2025-03-20 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof |
| CN120435498A (zh) * | 2022-11-10 | 2025-08-05 | 世纪治疗股份有限公司 | 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途 |
| WO2025207795A1 (en) * | 2024-03-26 | 2025-10-02 | Juno Therapeutics, Inc. | Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025207798A1 (en) * | 2024-03-26 | 2025-10-02 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025214438A1 (zh) * | 2024-04-10 | 2025-10-16 | 浙江纳米抗体技术中心有限公司 | 结合cd19和/或cd22的抗原结合分子及其用途 |
| CN121537531B (zh) * | 2026-01-16 | 2026-07-21 | 北京肿瘤医院(北京大学肿瘤医院) | 一种表达cd47-cd28共刺激转换受体的嵌合抗原受体及其应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8846395B2 (en) | 2005-06-01 | 2014-09-30 | Wisconsin Alumni Research Foundation | Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors |
| KR100902340B1 (ko) | 2007-08-02 | 2009-06-12 | 한국생명공학연구원 | Yc-1 또는 il-21을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법 |
| ES2587395T3 (es) | 2008-06-04 | 2016-10-24 | Cellular Dynamics International, Inc. | Procedimientos para la producción de células IPS usando un enfoque no vírico |
| JP5652783B2 (ja) | 2008-09-08 | 2015-01-14 | 独立行政法人理化学研究所 | NKT細胞由来iPS細胞およびそれ由来のNKT細胞 |
| CA2753679C (en) | 2009-02-27 | 2021-03-02 | Cellular Dynamics International, Inc. | Differentiation of pluripotent cells |
| PT2816112T (pt) | 2009-12-10 | 2018-11-20 | Univ Iowa State Res Found Inc | Modificação do adn modificada pelo efector tal |
| EP2601289B1 (en) | 2010-08-04 | 2017-07-12 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| AU2015290554A1 (en) | 2014-07-18 | 2017-03-09 | Kyoto University | Method for inducing T cells for cell-based immunotherapy from pluripotent stem cells |
| WO2017070333A1 (en) | 2015-10-20 | 2017-04-27 | Cellular Dynamics International, Inc. | Multi-lineage hematopoietic precursor cell production by genetic programming |
| LT3444334T (lt) | 2016-04-15 | 2021-12-10 | Kyoto University | Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas |
| JP7215994B2 (ja) | 2016-09-06 | 2023-01-31 | ザ チルドレンズ メディカル センター コーポレーション | 人工多能性幹細胞由来の免疫細胞 |
| KR102397771B1 (ko) | 2016-09-23 | 2022-05-13 | 프레드 헛친슨 켄서 리서치 센터 | 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도 |
| TW201908335A (zh) | 2017-07-25 | 2019-03-01 | 美國德州系統大學評議委員會 | 增強之嵌合抗原受體及其用途 |
| EP3684816B1 (en) | 2017-09-22 | 2024-05-29 | Kite Pharma, Inc. | Chimeric polypeptides and uses thereof |
| EP3692057B9 (en) | 2017-10-03 | 2023-10-04 | Precision BioSciences, Inc. | Modified epidermal growth factor receptor peptides for use in genetically-modified cells |
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| WO2020069184A2 (en) * | 2018-09-26 | 2020-04-02 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-cd19/cd22 immunotherapy |
| EP4041759A4 (en) * | 2019-10-07 | 2023-12-20 | Fate Therapeutics, Inc. | IMPROVED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTIVE CELL ENGINEERING AND ITS USE |
| WO2021092252A1 (en) * | 2019-11-05 | 2021-05-14 | Forman Stephen J | Generation of chimeric antigen receptor modified t cells from stem cells and therapeutic uses thereof |
| JP7805928B2 (ja) * | 2019-11-26 | 2026-01-26 | ノバルティス アーゲー | Cd19及びcd22キメラ抗原受容体及びその使用 |
| WO2021188599A1 (en) * | 2020-03-16 | 2021-09-23 | University Of Southern California | Novel antigen binding domains and synthetic antigen receptors incorporating the same |
| KR20230040337A (ko) * | 2020-06-19 | 2023-03-22 | 페이트 세러퓨틱스, 인코포레이티드 | 면역요법 사용을 위한 iPSC-유래 이펙터 세포 유형들의 조합 |
| TW202241935A (zh) * | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
-
2022
- 2022-12-27 WO PCT/US2022/082441 patent/WO2023129937A1/en not_active Ceased
- 2022-12-27 EP EP22856960.4A patent/EP4456912A1/en active Pending
- 2022-12-27 JP JP2024539426A patent/JP2025501214A/ja active Pending
- 2022-12-27 AU AU2022423987A patent/AU2022423987A1/en active Pending
- 2022-12-27 US US18/722,839 patent/US20250064934A1/en active Pending
- 2022-12-27 CA CA3243966A patent/CA3243966A1/en active Pending
- 2022-12-29 TW TW111150534A patent/TW202342734A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7745032B2 (ja) | 一本鎖および多鎖キメラポリペプチドならびにその使用方法 | |
| JP7781243B2 (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| JP2024519515A5 (cg-RX-API-DMAC10.html) | ||
| JP2023553419A5 (cg-RX-API-DMAC10.html) | ||
| JP7091447B2 (ja) | 新型なscFvアミノ酸配列、それを含むキメラ抗原受容体、およびその使用 | |
| JP6499245B2 (ja) | 形質導入T細胞選択のためのトランケート上皮増殖因子レセプタ(EGFRt) | |
| CN112469829B (zh) | 包含抗gpc3单链抗体的car | |
| JP2024513906A5 (cg-RX-API-DMAC10.html) | ||
| US12060394B2 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
| CN107660213B (zh) | 人源化抗MUCl*抗体 | |
| US11957717B2 (en) | Anti-human MSLN antibody and MSLN-targeting immune effector cell | |
| CN112955465A (zh) | 抗tcr抗体分子及其用途 | |
| CN116234829A (zh) | 抗tcr抗体分子及其用途 | |
| JP2023515211A5 (cg-RX-API-DMAC10.html) | ||
| KR20210019993A (ko) | Τ 세포 수용체 및 이를 발현하는 조작된 세포 | |
| JP2022553818A (ja) | 二重標的キメラ抗原レセプターt細胞療法のためのプロテアーゼスイッチ | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| CN111556756A (zh) | 重组免疫细胞、制备方法和使用方法 | |
| CN117597359A (zh) | 与tcr结合的多功能分子及其用途 | |
| CN118786150A (zh) | 与tcr结合的多功能分子及其用途 | |
| TW201905198A (zh) | 用於降低嵌合刻痕受體之免疫原性的方法與組合物 | |
| JP2023515747A (ja) | 免疫調節分子を発現する細胞および免疫調節分子を発現するための系 | |
| RU99101121A (ru) | Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение | |
| EP4061385A1 (en) | A method for redesign and expansion of nk92 cells for use in immunotherapy | |
| WO2021115333A1 (zh) | 一种融合蛋白及表达此蛋白的工程化免疫细胞及其应用 |